BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results

    NEXT STORY
    Stemline Therapeutics to Host Conference Call on Third Quarter 2019 Financial Results on November 8, 2019
    PREV STORY
    Aptose Reports Results for the Third Quarter Ended September 30, 2019
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Coherus Secures Private Placement from Temasek

    REDWOOD CITY, Calif., Aug. 21, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS) today ...

    author_avatar
    NASDAQ Market News

    Vir Biotechnology Initiates Phase 1 Clinical Trial of VIR-3434 for Chronic Hepatitis B Virus Infection

    author_avatar
    NASDAQ Market News

    Leap Therapeutics Reports Second Quarter 2018 Business Update and Financial Results

    CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology ...

    author_avatar
    NASDAQ Market News